KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV)
CUSIP: 483497103
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 50,580,036
- Total 13F shares
- 36,263,336
- Share change
- +1,818,240
- Total reported value
- $349,220,877
- Put/Call ratio
- 38%
- Price per share
- $9.63
- Number of holders
- 101
- Value change
- +$17,912,528
- Number of buys
- 50
- Number of sells
- 35
Quarterly Holders Quick Answers
What is CUSIP 483497103?
CUSIP 483497103 identifies KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 483497103:
Top shareholders of KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TCG Crossover Management, LLC |
13F
|
Company |
6.7%
|
3,395,495
|
$30,559,455 | — | 30 Jun 2023 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
6.4%
|
3,238,859
|
$29,149,731 | — | 30 Jun 2023 | |
| VR Adviser, LLC |
13F
|
Company |
5.8%
|
2,916,667
|
$26,250,003 | — | 30 Jun 2023 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
5.2%
|
2,651,393
|
$23,862,537 | — | 30 Jun 2023 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
4%
|
2,034,506
|
$18,310,554 | — | 30 Jun 2023 | |
| Boxer Capital, LLC |
13F
|
Company |
3.3%
|
1,650,000
|
$14,850,000 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.2%
|
1,599,738
|
$14,397,642 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.1%
|
1,580,681
|
$14,226,129 | — | 30 Jun 2023 | |
| Saturn V Capital Management LP |
13F
|
Company |
2.8%
|
1,412,336
|
$12,711,024 | — | 30 Jun 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.2%
|
1,104,339
|
$9,939,051 | — | 30 Jun 2023 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
2%
|
1,035,935
|
$9,323,415 | — | 30 Jun 2023 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
2%
|
1,030,000
|
$9,270,000 | — | 30 Jun 2023 | |
| Vivo Capital, LLC |
13F
|
Company |
1.7%
|
856,008
|
$7,704,072 | — | 30 Jun 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.7%
|
846,606
|
$7,619,454 | — | 30 Jun 2023 | |
| MPM BioImpact LLC |
13F
|
Company |
1.5%
|
761,538
|
$6,853,842 | — | 30 Jun 2023 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
720,508
|
$6,484,572 | — | 30 Jun 2023 | |
| Opaleye Management Inc. |
13F
|
Company |
1.4%
|
720,000
|
$6,480,000 | — | 30 Jun 2023 | |
| DAFNA Capital Management LLC |
13F
|
Company |
1.2%
|
611,032
|
$5,499,288 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.95%
|
480,425
|
$4,323,825 | — | 30 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.88%
|
446,175
|
$4,015,575 | — | 30 Jun 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.83%
|
420,536
|
$3,784,862 | — | 30 Jun 2023 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0.78%
|
392,504
|
$3,532,536 | — | 30 Jun 2023 | |
| Commodore Capital LP |
13F
|
Company |
0.62%
|
312,553
|
$2,812,977 | — | 30 Jun 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.59%
|
299,808
|
$2,698,272 | — | 30 Jun 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.58%
|
293,311
|
$2,639,799 | — | 30 Jun 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.57%
|
290,275
|
$2,612,475 | — | 30 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.52%
|
261,616
|
$2,354,544 | — | 30 Jun 2023 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.4%
|
204,720
|
$1,842,480 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.4%
|
202,623
|
$1,823,607 | — | 30 Jun 2023 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.35%
|
178,292
|
$1,604,628 | — | 30 Jun 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.28%
|
142,928
|
$1,286,000 | — | 30 Jun 2023 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.28%
|
140,200
|
$1,261,800 | — | 30 Jun 2023 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.28%
|
140,000
|
$1,260,000 | — | 30 Jun 2023 | |
| AlphaCentric Advisors LLC |
13F
|
Company |
0.27%
|
135,000
|
$1,215,000 | — | 30 Jun 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.26%
|
133,122
|
$1,198,098 | — | 30 Jun 2023 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.24%
|
121,353
|
$1,092,000 | — | 30 Jun 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.23%
|
116,862
|
$1,051,758 | — | 30 Jun 2023 | |
| Woodline Partners LP |
13F
|
Company |
0.21%
|
108,358
|
$975,222 | — | 30 Jun 2023 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.21%
|
107,975
|
$971,775 | — | 30 Jun 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.2%
|
99,162
|
$892,458 | — | 30 Jun 2023 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.18%
|
88,600
|
$797,400 | — | 30 Jun 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.16%
|
82,801
|
$745,209 | — | 30 Jun 2023 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.14%
|
72,540
|
$652,860 | — | 30 Jun 2023 | |
| FMR LLC |
13F
|
Company |
0.14%
|
70,865
|
$637,785 | — | 30 Jun 2023 | |
| HighVista Strategies LLC |
13F
|
Company |
0.14%
|
69,567
|
$626,103 | — | 30 Jun 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.13%
|
65,154
|
$586,386 | — | 30 Jun 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.12%
|
61,783
|
$556,047 | — | 30 Jun 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.12%
|
59,971
|
$539,739 | — | 30 Jun 2023 | |
| CIBC WORLD MARKETS CORP |
13F
|
Company |
0.1%
|
50,000
|
$450,000 | — | 30 Jun 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.08%
|
41,731
|
$375,579 | — | 30 Jun 2023 |
Institutional Holders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) as of Q3 2023
As of 30 Sep 2023,
KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) was held by
101 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,263,336 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, TCG Crossover Management, LLC, Frazier Life Sciences Management, L.P., VR Adviser, LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, Saturn V Capital Management LP, VANGUARD GROUP INC, Boxer Capital, LLC, BlackRock Inc., and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
101
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
93
Q3 2023 holders
101
Holder diff
8
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.